跳至主要内容
临床试验/NCT05427214
NCT05427214已完成不适用

A Prospective Imaging Study of Target Definition and Simulation-free Planning Workflows on the Halcyon 4.0 System for Patients Receiving Radiation Therapy

Washington University School of Medicine1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2022年8月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
1
主要终点
Percentage of images that are of sufficient quality for patient primary treatment plan construction

研究概览

简要总结

This prospective imaging study is evaluating the feasibility of using the Halcyon 4.0 radiotherapy system for radiation therapy planning in patients with cancer. The Halcyon 4.0 system has been engineered to decrease the image acquisition time and the radiation exposure, but the system has not yet been clinically validated for use in radiation planning. This pilot study will evaluate images obtained on the Halcyon 4.0 system to assess if the quality is sufficient for radiation treatment plan construction.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Eligibility Criteria:
  • •Planning to receive radiation therapy to one of the following sites:
  • •Head and neck/brain (n=10)
  • •Thorax (n=10)
  • •Abdomen (n=10)
  • •Pelvis (n=10)
  • •At least 18 years of age
  • •If the patient will be receiving IV contrast on study: Adequate renal function as defined by a serum creatinine < 1.4, or, for patients with chronic kidney disease, a stable serum creatinine < 2.
  • •Note: if no IV contrast will be administered on study, patient may enroll without creatinine level documented.
  • •If the patient is a woman of childbearing potential, a negative pregnancy test must be obtained. Contraceptive use is not an adequate documentation of no chance of pregnancy.
  • •Able to understand and willing to sign an IRB approved written informed consent document.

排除标准

  • 未提供

研究组 & 干预措施

Halcyon 4.0 imaging

Experimental

Patients planning to receive radiation therapy to the head and neck/brain, thorax, abdomen, or pelvis will undergo imaging on the Halcyon 4.0 system. Patients will return for a minimum of 2 sessions over 9 weeks, with a cumulative total of 10 images being collected.

干预措施: Halcyon 4.0 system (Device)

结局指标

主要结局

Percentage of images that are of sufficient quality for patient primary treatment plan construction

时间窗: At 9 weeks

If the treatment target and surrounding organs at risk can be visualized and contoured for treatment planning purposes and a treatment plan created that meets the stated objectives ( or better than the stated objectives), then the kV CBCT images will be deemed feasible.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验